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Abstract
Background: Metabolic resistance of the major malaria vector Anopheles gambiae (s.l.) to insecticides is
operationally significant, particularly in combination with target site resistance. However, detection of metabolic
resistance is not trivial and relies on laborious bioassays, unspecific biochemical methods, or sophisticated and
expensive molecular approaches using transcriptomics.
Methods: Rapid one-step multiplex TaqMan-probe based RT-qPCR assays were developed and optimised to
measure the expression levels of genes associated with metabolic insecticide resistance in An. gambiae (s.l.). Primers
and probes were designed to target the mRNA of cytochrome P450-dependent monooxygenases CYP6P3, CYP6M2,
CYP9K1, CYP6P4 and CYP6Z1, and the glutathione-S-transferase GSTE2. The novel assays were validated versus gold
standard methods with a range of phenotyped mosquito specimens. The assays were also tested directly on lysates
of RNAlater®-preserved mosquitoes without an RNA extraction step.
Results: The novel assays are efficient (reaction efficiencies = 95–109%), sensitive (covering a > 10.0 Ct range with
R2 values > 0.99), specific (TaqMan chemistry), reproducible (%CV = 4.46–12.07%), as well as readily expandable to
capture additional loci as they evolve or to cover additional species. The assays were successfully validated in terms of
expression levels against standard two-step singleplex qPCR assays (overall % difference = -17.6%, 95% CI = -38.7–3.43%)
and microarrays, using laboratory strains and field-caught samples. The assays can also be applied directly on lysates of
mosquito specimens, without RNA extraction or DNase treatment.
Conclusions: The novel multiplex assays for monitoring the levels of major detoxification genes and metabolic resistance
in An. gambiae (s.l.) are simple to perform, robust and rapid. They may complement current diagnostic assays to provide
evidence-based and operationally relevant information for insecticide resistance management.
Keywords: Multiplex TaqMan assays, Detoxification, P450s, GSTEs, Insecticide resistance, Metabolic resistance, Gene
expression
Background
Insecticide based vector control interventions have reduced
malaria incidence [1]. However, the increasing use of a lim-
ited number of insecticides, primarily pyrethroids, places an
immense selection pressure on insect populations, which
has not left disease vectors unaffected [2, 3]. The resulting
insecticide resistance (IR) in the major malaria vector
Anopheles gambiae (s.l.) represents one of the greatest
challenges in malaria control. In Anopheles mosquitoes,
resistance is primarily conferred by mutations at the
insecticide’s target site that alter its sensitivity, and by the
upregulation of enzymes that detoxify or sequester the in-
secticide [4]. Several cytochrome P450-dependent monoox-
ygenases have been functionally associated with pyrethroid
resistance. CYP6P3 [5] and CYP6M2 [6] are considered as
the main pyrethroid metabolising enzymes in several An.
gambiae populations in West Africa. CYP6Z1 is associated
with both pyrethroid and dichlordiphenyltrichlorethan
(DDT) resistance [7]. CYP6P4 is associated with resistance
to both alpha-cyano and non-alpha-cyano pyrethroids [8],
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and metabolises the juvenile hormone pyriproxyfen that is
used as insect growth regulator by preventing larvae from
developing into adult stages [9]. CYP9K1 was recently
found to be overexpressed in deltamethrin-resistant Bioko
populations and also metabolises pyrethroids [10]. The
glutathione-S-transferase GSTE2 is associated with DDT
[11] and pyrethroid [12] resistance.
Up-to-date data on resistance to insecticides are a pre-
requisite for the effective implementation of interventions.
While a multitude of high throughput assays for the detec-
tion of individual target site resistance mutations have been
developed and used to facilitate the implementation of vec-
tor control strategies [13, 14], there are very few such tools
available for monitoring metabolic insecticide resistance in
mosquito field populations [12]. In the absence of DNA
markers associated with overexpression of detoxification
genes for An. gambiae (s.l.), detection methods for meta-
bolic resistance are restricted to either phenotypic bioassays
with synergists or biochemical assays. Synergists are
compounds that inhibit metabolic detoxification enzymes.
By comparing the mortality of mosquitoes exposed to a
synergist followed by the insecticide to the mortality of
mosquitoes exposed to only the insecticide, a conclusion
can be drawn as to whether and which enzyme families are
involved in the observed resistance [15]. Two major draw-
backs of synergist-insecticide bioassays are that they require
large numbers of live mosquitoes and that they may only
indicate which enzyme class (e.g. P450s, GSTs or esterases)
is implicated and not specify which one of the enzymes is
overexpressed. Biochemical measurement of resistance
enzyme activity on microplates represents a simpler alter-
native to phenotypic response-to-exposure tests [16].
However, the biochemical assays’ generic substrates are
recognised by several members in an enzyme family and,
therefore, are equally non-specific. Synergist-insecticide
bioassays and biochemical assays are currently recom-
mended follow-up techniques to determine the resistance
mechanisms in resistant mosquito populations [17]. These
methods have indeed been useful to associate elevated
levels of mixed function oxidases with pyrethroid resistance
in the field, for example in An. gambiae from Kenya [18]
and in An. funestus from southern Africa [19] but they
could not specify which P450s were overexpressed. In an
attempt to have more specific assays available, chromo- and
fluorogenic substrates with a higher preference for insecti-
cide “metabolisers” have been identified or synthesised in
some cases [20, 21], with relatively restricted applicability
because of the limited availability of substrates and/or
complexity of biochemical reactions.
We believe that multiplex TaqMan assays are the future
for resource-efficient and high-throughput monitoring of
metabolic resistance in mosquito field populations. Here,
we developed novel and rapid multiplex detoxification
gene expression assays suitable for monitoring the specific
upregulation of genes responsible for metabolic resistance
in Anopheles mosquitoes. These qPCR assays were de-
signed in the framework of the interdisciplinary research
project DMC-MALVEC (dmc-malvec.eu) with the aim to
develop an automated diagnostic platform (LabDisk) for
malaria vectors [22], though they can also be applied inde-
pendently in conventionally prepared samples.
Methods
Mosquito samples: laboratory colonies and field-caught
populations
Non-blood-fed An. gambiae female mosquitoes were
preserved in RNAlater® 3–5 days post-eclosion. The fol-
lowing insecticide resistant strains were obtained
through BEI Resources, NIAID, NIH: strain AKRON,
bulk frozen, MRA-913B, contributed by Martin Akog-
beto; strain RSP, bulk frozen, MRA-334 and the strain
ZANU MRA-594, both contributed by Hilary Ranson
and Frank H. Collins. The VK7 and Tiassalé strains were
kindly provided by the Liverpool Insect Testing Estab-
lishment (LITE). The AKRON (MRA-913) strain carries
the L1014F kdr and G119S Ace-1 target site mutations
which leads to phenotypic resistance to carbamate [23].
The RSP (MRA-334) strain’s name stands for reduced
susceptibility to permethrin, which is caused by the
L1014S kdr mutation and increased cytochrome P450
and beta-esterase activity [24, 25]. The metabolic resist-
ance to DDT of the ZANU (MRA-594) strain is conferred
by elevated glutathionine-S-transferase and beta-esterase
activity [26]. The An. gambiae strain from Tiassalé in Côte
d’Ivoire exhibits the L1014F kdr and G119S Ace-1 muta-
tions as well as upregulation of several P450s [3, 27]. The
combination of these different resistance mechanisms leads
to multiple-insecticide resistance to pyrethroids (docu-
mented for permethrin and deltamethrin), organochlorides
(DDT), carbamates (bendiocarb) and organophosphates (fe-
nitrothion) in the Tiassalé strain. The VK7 strain’s high re-
sistance to pyrethroids and DDT is a consequence of
mutations in the common target site of these insecticides.
The effect of the fixed L1014F kdr mutation is enhanced by
the N1575Y super-kdr mutation in a substantial proportion
of the VK7 colony [28]. The Kisumu and Ngusso laboratory
colonies are susceptible to all above mentioned insecticides
and were used as control comparator strains in this study.
The insectary at the Swiss Tropical and Public Health Insti-
tute provided specimens of the Kisumu colony that origi-
nates from an MRA-762 egg batch provided by BEI
Resources [29]. The Ngusso specimens used in this study
were reared in the insectary of the Institute of Molecular
Biology and Biotechnology, Foundation for Research and
Technology-Hellas. The description of the characteris-
tics of the laboratory colonies included in the study is
summarised in Additional file 1: Table S1. Specimens
from a field-caught population from Bioko Island that
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was recently characterised [10] were also included in
the validation of the assays.
Nucleic acid extractions and preparation of samples
omitting the extraction step
Mosquitoes (10 individuals per sample) were mechanic-
ally disrupted using a tissue grinder and pestle in a 1.5
ml microcentrifuge tube with 200 μl TE buffer (10 mM
Tris-HCl, 1mM EDTA, pH 8.0). Nucleic acids (total
RNA and DNA) were extracted using the MagnaMedics
magnetic-bead based protocol (MagnaMedics GmbH,
Aachen, Germany). In brief, 150 μl lysis buffer were
added to the previously processed mosquitoes, followed
by 10 min incubation at room temperature and a centri-
fugation step at 16,000× g for 2 min in order to sediment
non-lysed tissue debris. The clear lysate supernatant was
incubated subsequently with 30 μl magnetic beads and
440 μl binding buffer for 10 min and was washed twice
with 200 μl wash buffer for 1 min. Nucleic acid elution
was performed with 150 μl elution buffer for 10 min at
50 °C. For the direct PCR approach, the clear lysate was
directly diluted 25× with DEPC-treated water and used
as a template for the RT-qPCR reactions. Smaller dilu-
tions were also tested but the 25× dilution was selected
due to both absence of inhibition and optimal sensitivity.
Nucleic acid integrity was assessed via agarose gel elec-
trophoresis (1.2% w/v).
Reverse transcription and singleplex qPCR based on SYBR
Green chemistry
As a reference method to measure gene expression, sin-
gleplex qPCR assays based on SYBR Green chemistry
were performed. cDNA was synthesized using 1 μg οf
total RNA, previously treated with TURBO™ DNase
(Invitrogen, Carlsbad, CA, USA), with oligo (dT)12-18
primers and the Thermoscript RT-PCR system kit (Invi-
trogen, Carlsbad, CA, USA), following the manufac-
turer’s instructions. The SYBR Green-based qPCR assays
were run in duplicates in 10 μl reactions, consisting of
2× Kapa SYBR® Fast Universal qPCR Master Mix (Kapa
Biosystems, Wilmington, MA, USA), forward and re-
verse primers specific for each gene (Additional file 1:
Table S2) at a final concentration of 200 nM as well as
20 ng of cDNA template. Bio-Rad CFX Connect™
Real-Time PCR Detection was used with a thermal
protocol consisting of a 3 min polymerase activation/ini-
tial denaturation step at 95 °C, 40 cycles of denaturation
and annealing/extension steps at 95 °C for 3 s, 60 °C for
30 s, followed by a melting curve analysis step. A
no-template control was included in each qPCR run.
Design of multiplex detox assays
A total of four triplex detox assays [Detox (A)-Detox (D)]
were designed using the three fluorophores, FAM (green),
HEX (yellow) and Atto647N (red) of the TaqMan probe
chemistry. Along with the 40S ribosomal protein S7
(RPS7; AGAP010592), CYP6P3 (AGAP002865) and
CYP6M2 (AGAP008212) compiled Detox (A), CYP9K1
(AGAP000818) and CYP6P4 (AGAP002867) Detox (B),
CYP6Z1 (AGAP008219) and GSTE2 (AGAP009194) De-
tox (C) and CYP6P1 (AGAP002868) and CYP4G16
(AGAP001076) Detox (D). The RPS7 target has previously
shown to be a suitable reference in An. gambiae [5, 6] and
was included in all assays to normalise each reaction for
variations in RNA concentrations.
Primers and probes for the multiplex TaqMan qPCR as-
says were designed de novo (Additional file 1: Table S2). In
addition to the standard guidelines for qPCR assays the
following criteria were considered: (i) at least one primer
was chosen to bridge the junction of two exons to avoid
DNA amplification (Additional file 2: Figure S1); (ii) speci-
ficity for each gene obtained both by amplification
(primers) and detection (probe) properties; and (iii)
avoiding cross-reactions with other targets in the same
multiplex.
Inclusivity was assessed in silico to ensure that the
newly developed triplex assays detect all sequences of
the target genes in An. gambiae. All available sequences
for each of the nine target genes were downloaded from
the NCBI Nucleotide database and analysed for matches
with the corresponding assay using the “Test with saved
primers” tool in Geneious 10.2.5 (Biomatters Ltd,
Auckland, New Zealand) [30].
In order to assess the exclusivity in terms of sequences
and the sibling species of the An. gambiae complex, the
primers and probes included in the assays from each
multiplex were analysed in silico. The Perl script Simula-
te_PCR [31] was used together with BLAST+ 2.7.1 [32].
Briefly, a list with all primers and probes was used to
perform a BLAST search against two different databases:
the nt database (downloaded from the NCBI BLAST ftp
site, version from 08/06/2018) and a list with all DNA
sequences available for mosquitoes of the An. gambiae
species complex in VectorBase [33]. The Simulate_PCR
script analyses the BLAST output to look for pairs of
primers that could produce an amplicon and only oligos
with 4 or fewer mismatches with the target sequence
were considered. The amplicons were also only consid-
ered if the size was between 40 bp and 500 bp. With the
software it was also checked that a probe bound within
the potential amplicons.
Primers were also analysed with the software
Autodimer-1 [34] for the potential formation of primer
dimers between those pairs present in the same multi-
plex assay. The software calculates a score based on the
number of matches (+1) and mismatches (-1) between 2
oligos. The recommended threshold of 7 for this score
was used without any potential dimer found. Further
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tests were performed with more liberal conditions and
the most stable of the interactions identified had a Tm of
29.7 °C and a deltaG of -3.96 kcal/mole. These interac-
tions were deemed not relevant as the lowest temperature
used during the qPCR is 60 °C and the regular threshold
for deltaG on primer dimers is -5 kcal/mole.
Multiplex RT-qPCR Taqman assays
All oligos were optimised in terms of reaction efficiency
and sensitivity by prioritising on those oligos that yielded
an early Ct value at the lowest concentration. To facilitate
the selection process, the reactions with combinations of
oligos at different concentrations were carried out and
plotted in a heat diagram (Additional file 2: Figure S2) and
the pairs that gave maximum yield with the lowest con-
centrations were chosen. After primer optimisation a
range of probe concentrations were also tested following
the same criterion as well as fluorescence signal strength.
To verify the absence of crosstalk and background signal,
each target was amplified individually using corresponding
plasmid controls. Additionally, all assays were run com-
paratively on the same plate in triplex and singleplex for-
mats. The one-step reverse transcription qPCR
(RT-qPCR) mastermix that was used in this study was
supplied by Fast Track Diagnostics (Esch-sur-Alzette,
Luxembourg). Nucleic acids of at least 100 ng per sample
were used in a total reaction volume of 10 μl with the
primer-probe concentrations given in Additional file 1:
Table S2. The thermal cycle parameters were: 50 °C
for 15 min, 95 °C for 3 min, and 40 cycles of 95 °C
for 3 s and 60 °C for 30 s. The reactions were per-
formed in 96-well plates in a ViiA 7 Real-Time PCR
System (Applied Biosystems, Waltham, MA, USA).
Samples were amplified in duplicates and each run
always included a non-template control.
The sensitivity and specificity of the RT-qPCR assays
developed were evaluated through quality control proce-
dures consisting of: (i) the construction of standard
curves for all genes both in singleplex and in multiplex
formats; (ii) including a control sample consisting of
RNase treated template to ensure only mRNA and no
gDNA is amplified; (iii) visualisation of the amplicons by
agarose gel electrophoresis for all amplicons to check for
the presence of a unique band with the expected length
of each amplicon’s mRNA (Additional file 2: Figure S3);
and (iv) estimating assay reproducibility, expressed by
the coefficient of variation (CV), by analysing a series of
samples within the same and different runs. The analyt-
ical parameters of the RT-qPCR reactions are presented
in details in Table 1.
Following quality control, the newly-developed multi-
plex detox assays were used to measure gene expression
in laboratory colonies for which data were available,
from the literature and/or from publicly available
databases for the expression profiles of the genes in-
cluded in our assays. Akron, a multi-resistant laboratory
colony [35], was also used in this analysis. The same sus-
ceptible laboratory strain as reported in each published
study/database was used for comparison. Additionally,
the standard two-step singleplex RT-qPCR with SYBR
Green chemistry was performed for each gene and the %
difference between the fold changes measured by the
multiplex and singleplex approaches was calculated as de-
scribed in the Bland Altman analysis [36].
Statistical analysis
Calculation of fold changes and P-values were assessed
by the method of Pfaffl et al. [37], implemented in the
REST 2009 software v2.013 that allows inputting Ct
values for controls (susceptible population) and samples
(resistant population) for each gene and returning fold
changes for the resistant population with 95% confi-
dence intervals (CIs) and P-values. The Ct values of nor-
maliser and each target gene for each sample are jointly
reallocated to susceptible and resistant groups and the
fold changes are calculated on the basis of mean values
after 2000 iterations. This statistical model described by
Pfaffl et al. (Pair Wise Fixed Reallocation Randomization
test©) [37] has the advantage of making no distributional
assumptions and at the same time do not suffer a reduc-
tion in power relative to standard parametric tests.
Graphs were produced using SigmaPlot v12.0 software.
For the correlation analysis between expression levels,
the latter were calculated as relative quantification (RQ)
units (RQ = 2-ΔCt, where ΔCt = Cttarget - Ctnormaliser).
The level of significance was set at α = 0.05.
Results
Control of quality, analytical performance and of
multiplex detox assays. Demonstration of expression
analysis
The in silico inclusivity analysis predicted that all
mRNA sequences available for all genes and their
isoforms, where applicable, were bound by the corre-
sponding oligonucleotides with either perfect match-
ing or no more than one mismatch in either the
reverse or the forward primer. This suggests that all
sequences will be detectable with these new assays.
Exclusivity analysis showed that only the nine ex-
pected targets and no other sequence are amplifiable
and detectable with the new triplex assays in An.
gambiae (s.l.). No amplicon with oligonucleotides
from different assays is expected and the sequence
analysis found no potential primer dimers between
the oligos present in the same multiplex mix.
Results from the standard curve analysis showed
similar and within the accepted range [38] efficiencies
(95–109%) and R2 values (0.989–0.999) both for single-
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and multi-plex reactions for each gene. Assay reproduci-
bility ranged from %CV = 4.46–12.07% for multiplex
and %CV = 9.52–16.03% for singleplex reactions. The
quality control data are described in detail in Table 1.
No detectable signal was obtained from DNA samples,
verifying the validity of primer design across junctions
(Additional file 2: Figure S1). The presence of a unique
band with the expected length of each amplicon’s mRNA
was verified and additional specificity was achieved with
probe hybridisation specific for each gene (Additional
file 2: Figure S3 and Additional file 2: Figure S1).
As an example of the expression analysis output ob-
tained with the new multiplex TaqMan assays, Fig. 1
shows that the multiple-insecticide resistant Akron
strain overexpresses all eight detoxification genes com-
pared to the susceptible Kisumu strain. In Fig. 1a-d, the
amplification curves of all genes belonging to the four
triplex assays are shown; it is clear that for all detoxifica-
tion genes there are lower Ct values in the resistant
compared to the susceptible sample, whereas no change
was observed for the RPS7 reference gene, indicating a
clear upregulation of the target (detoxification) genes. In
Fig. 1e-h the fold-upregulation for gene is presented
along with 95% CIs and P-values produced as a simple
output by the REST 2009 software.
Validation of the diagnostic performance of multiplex
detox assays using laboratory mosquito colonies
Overall, the newly developed multiplex TaqMan assays
produced comparable results with the standard two-step
singleplex RT-qPCR method (Table 2). The expression
levels defined by the two methods showed a statistically
significant correlation for all genes. The overall % differ-
ence in fold change determination between the two
methods was -17.6%, and no significant bias was
detected (95% CI of % difference = -38.7–3.43%).
For each individual gene, a direct comparison of the
results obtained from the novel multiplex TaqMan as-
says, standard singleplex SYBR Green based qPCR and
publicly available data is presented in Table 2. CYP6P3
and CYP6M2 were upregulated in the Tiassalé vs
Ngousso comparison in the literature (29.5× and 6.41×),
the singleplex RT-qPCR (15.1× and 4.99×) and the
multiplex Detox (A) panel (20.7× and 4.46×). Both genes
were also upregulated in VK7 compared to Ngousso.
CYP9K1 and CYP6P4 were upregulated 4.33× and 14.4×
in Tiassalé vs Ngousso according to the literature, which
is consistent with the 2.01× and 13.0× upregulation ob-
served using the Detox (B) panel, and which was further
confirmed with singleplex qPCR (4.60× and 8.33×
upregulation). Similarly, CYP6Z1 and GSTE2 have been
previously identified to be significantly overexpressed
(3.50- and 7.80-fold) in both RSP and ZANU resistant
strains when compared with the susceptible Kisumu
strain and this observation is validated both by the newly
developed multiplex Detox assay (C) panel (3.03- and
57.8-fold) and the singleplex qPCR (2.69- and 22.7-fold).
According to published data CYP6P1 and CYP4G16 are
marginally upregulated in the resistant VK7 when com-
pared to the susceptible Ngousso strain (2.20- and
1.90-fold, respectively). This marginal difference in gene
expression is also observed when assaying the same
strains with the Detox assay (D) panel (1.55- and
2.03-fold) and singleplex qPCR (2.64- and 2.63-fold).
Additionally, differences that are not statistically sig-
nificant according to published data and the standard
singleplex RT-qPCR are also concordant with the multi-
plex detox assays. These negative predictive properties
of our method were found for CYP6Z1, GSTE2 and
CYP4G16 in Tiassalé vs Ngousso comparisons and
CYP9K1 in VK7 vs Ngousso comparison.
Validation of the diagnostic performance of multiplex
detox assays with field-caught specimens
In addition to the experiments above, RNA templates
from two deltamethrin-resistant field populations, here-
after named “Industrial” and “Hospital”, from the Ela
Nguema district of Malabo in Bioko (described in detail
Table 1 Quality control characteristics of the qPCR reactions
Gene (assay) % Reaction efficiency (M) % Reaction efficiency (S) R2 (M) R2 (S) Dynamic range (M) Dynamic range (S) %CV (M) %CV (S)
RPS7 (Detox A-D) 104 103 0.999 0.998 16.50–31.00 16.20–31.00 8.89 9.52
CYP6P3 (Detox A) 107 102 0.999 0.991 25.70–32.92 25.96–33.46 9.99 12.37
CYP6M2 (Detox A) 109 103 0.998 0.996 26.39–32.97 26.44–34.31 9.64 10.41
CYP9K1 (Detox B) 105 101 0.994 0.989 20.22–31.67 20.74–32.02 6.50 9.64
CYP6P4 (Detox B) 109 107 0.996 0.996 25.54–33.94 25.83–34.30 4.46 10.41
CYP6Z1 (Detox C) 99 95 0.995 0.997 23.37–33.63 23.29–33.29 5.54 9.99
GSTE2 (Detox C) 100 96.1 0.999 0.998 23.25–33.36 23.62–33.69 12.07 16.03
CYP6P1 (Detox D) 97 95 0.997 0.996 24.66–34.17 24.87–34.27 10.37 13.55
CYP4G16 (Detox D) 100 98 0.999 0.998 19.22–30.30 19.52–30.40 9.02 12.24
Abbreviations: M, multiplex; S, singleplex; CV, coefficient of variation at the expression units level
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in [10]) were included in this study. Here, the idea was
to further validate the multiplex approach against add-
itional methods, two step singleplex RT-qPCR and DNA
microarrays, by measuring the fold changes in expres-
sion levels of the eight detoxification genes between the
field mosquitoes and a susceptible Kisumu lab colony
[10]. Indeed, the estimated fold changes between the
two Bioko field populations and the susceptible lab col-
ony were in good agreement between all three methods
(Fig. 2). For example, CYP9K1 showed a 4.21-fold
Fig. 1 Amplification curves for the four triplex Detox assays (a-d) and corresponding expression analysis (e-h) using the REST software. Asterisks
indicate statistical significance (P ≤ 0.05) (Pfaffl et al. [37]; Pair Wise Fixed Reallocation Randomization test©). Abbreviations: R, resistant sample
(Akron strain); S, susceptible sample (Kisumu strain)
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upregulation in the “Industrial” population as shown by
the microarrays of the initial study (Fig. 2a). In the two
step singleplex RT-qPCR assays the fold change was 7.82
(95% CI: 4.14–11.5) and the current assays yielded a
4.27-fold (95% CI: 2.07–7.49) change. In the Hospital
population the microarray output reports a 5.3-fold
overexpression for CYP9K1 (Fig. 2b), which agrees with
the 7.35-fold (95% CI: 3.79–11.4) upregulation found
with the multiplex detox assays and 11.6-fold (95% CI:
6.25–17.0) in the two step singleplex RT-qPCR method.
Similarly, highly consistent comparative results between
the three methods were obtained for CYP6P3, CYP9K1,
CYP6P4, CYP6M2 and CYP6Z1 for both the Industrial
(Fig. 2a) and Hospital (Fig. 2b) field populations. The
complete expression analysis results are presented in
Additional file 1: Table S3 for the Industrial area and in
Additional file 1: Table S4 for the Hospital area population.
For GSTE2, CYP6P1 and CYP4G16 no singleplex
RT-qPCR data are available because they were not
followed up in the original study given the microarrays
Fig. 2 Expression analysis in field-caught samples from Bioko Industrial (a) and Hospital (b) areas vs the Kisumu susceptible strain (n = 3 replicates
each), showing accordance between the multiplex detox assays and two different methodologies (microarrays and SYBR Green singleplex RT-
qPCR). Levels in error bars indicate 95% CIs; asterisks indicate statistical significance (P ≤ 0.05)
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showed no differential expression. These observations
are confirmed by our method.
Ultra-rapid and cost-efficient application of the validated
multiplex detox assays with the direct RT-qPCR approach
In order to provide an even more rapid and
cost-effective format for analysing detoxification gene
expression levels, the possibility of omitting the nucleic
acid extraction step was assessed. In order to measure
the effect of omitting the extraction step, mosquitoes
from the susceptible Kisumu and the resistant Akron
colonies were homogenised and lysed before they were
divided into two aliquots. Nucleic acids were extracted
from the one aliquot, while the other aliquot served dir-
ectly as a RT-qPCR template after it was further diluted
at a 1:25 ratio. Expression analysis data obtained from
the aliquot that was directly subjected to RT-qPCR were
completely consistent with those obtained from the ali-
quot from which the nucleic acids were purified. For ex-
ample, in the comparison between resistant and
susceptible mosquitoes using the Detox (A) assay, CYP6P3
was found to be overexpressed 4.68× (95% CI: 2.67–8.81)
with the direct RT-qPCR approach compared with a
4.10-fold overexpression (95% CI: 3.35–5.23) when
following the standard nucleic acid extraction procedure.
Similarly, the difference for CYP6M2 was minor between
the two approaches (4.57-fold compared to 2.70-fold
upregulation for direct RT-qPCR compared to standard
procedure, respectively). Detailed results for all genes are
presented in Table 3. To corroborate this analysis, gene
expression values obtained from the two approaches were
also correlated and correlation coefficients indicated a
significantly strong correlation (r > 0.9 in most cases)
(Additional file 1: Table S5). Figure 3 provides an
easy-to-follow three-step overview of the direct RT-qPCR
procedure from sample-to-result for which only 95 min
are needed.
Discussion
We developed a simple, robust, rapid and cost-effective
method for determining the expression levels of major
detoxification genes that have been associated with
metabolic resistance in the malaria vector An. gambiae.
The assay is based on specific TaqMan probes and RT,
and it can reliably determine the expression levels of the
pyrethroid metabolisers CYP6P3, CYP6M2, CYP9K1,
CYP6P4, CYP6Z1 and GSTE2, which have been func-
tionally implicated in metabolic pyrethroid resistance in
An. gambiae. The assay panel is also readily expandable
to capture additional loci as they evolve, or to cover
other mosquito vectors.
The method was developed and successfully validated
with mosquito specimens from both laboratory colonies
and field collections. The results obtained are consistent
(both in terms of extent of upregulation and statistical
significance) with previously-used methods regarded as
gold standards for gene expression determination, such
as the two-step standard singleplex qPCR and microar-
rays, which are far more expensive and complex. The
comparative analysis between multiplex TaqMan assays
and SYBR Green singleplex qPCR did not reveal signifi-
cant discordance for the majority of genes (Table 2) with
the exception of CYP6P1 (95% CI of %difference: -111–
-8.5, not including the null value). Furthermore, compared
to other genes, CYP9K1 and CYP4G16 show relatively no-
ticeable differences in fold changes between multiplex and
singleplex assays (-56.5% and -51.2% difference, respect-
ively). A possible explanation for this observation could be
given by the fact that CYP6P1, CYP4G16 and CYP9K1 are
among the genes that did not show large or statistically
significant differences in most of the available compari-
sons between the lab strains of Table 2, so some variability
in determinations between methods is expected. However,
even for these genes, available data from the third inde-
pendent method (microarrays) were in every case in better
agreement with the newly developed multiplex, rather
Table 3 Gene expression analysis performed in mosquito lysates by direct qPCR and matched purified eluates after nucleic acid
extraction (n = 4 susceptible vs n = 4 resistant). P values were calculated by the pair wise fixed reallocation randomization test
Gene
(Detox
assay)
Direct qPCR in lysates qPCR in matched nucleic acid extracted eluates
Fold change (95% CI) P-value Fold change (95% CI) P-value
CYP6P3 (A) 4.68 (2.67–8.81) 0.001 4.10 (3.35–5.23) 0.020
CYP6M2 (A) 4.57 (3.18–7.19) 0.002 2.70 (2.18–3.40) 0.022
CYP9K1 (B) 4.66 (3.40–7.70) 0.002 4.45 (4.12–4.80) <0.001
CYP6P4 (B) 2.29 (1.31–3.71) 0.018 1.67 (1.33–2.11) <0.001
CYP6Z1 (C) 2.98 (2.47–3.84) 0.009 1.85 (1.44–2.22) <0.001
GSTE2 (C) 13.6 (9.64–18.4) 0.008 9.36 (7.96–11.9) <0.001
CYP6P1 (D) 1.32 (0.968–1.90) 0.060 1.64 (0.752–3.57) 0.215
CYP4G16 (D) 2.81 (1.61–4.26) 0.008 1.91 (1.45–2.46) <0.001
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than the singleplex assays (Table 2, Additional file 1: Table
S3 and Additional file 1: Table S4). All points above sug-
gest that our multiplex assays represent a valid alternative
to conventional two-step singleplex qPCR. The “closed--
tube” nature of the TaqMan platform means that there is
no requirement for post-PCR processing and conse-
quently assays are simple to perform and rapid to run,
while the output is easy to produce and interpret. A ne-
cessary requirement for these triplex-assay is a real-time
PCR machine equipped with three detection channels.
Such machines are generally more expensive (approximate
price range = 20,000–25,000 €) than machines with only
two detection channels (approximate price range =
10,000–15,000 €), but there is currently fast progress in
the development of cheap portable field-deployable
real-time qPCR thermocyclers. The investment in a flex-
ible multi-channel qPCR machine is worthwhile because
multiplex qPCR assays have much lower running cost. In
Table 4 we estimated the cost for measuring the gene ex-
pression levels of the eight detox genes and one normal-
iser gene for 12 samples. For the singleplex approach at
least 2.25× more mastermix and plastic consumables are
needed than for the multiplex assay, while the multiplex
method only requires additional TaqMan probes that cost
roughly 10 € extra per 96-well plate. The total consum-
ables and reagents for the multiplex TaqMan assay cost
approximately half as much as for the same tests with the
singleplex SYBR Green assay.
Furthermore, the presented assays run with mos-
quito lysates without the requirement of prior RNA
extraction and DNase treatment steps due to the pri-
mer design across exons. The results suggest that
there is little, if any, loss in sensitivity, compared to
standard nucleic acid extraction approaches. The
extraction-free multiplex RT-qPCR method is easier
to perform than the singleplex assays, reliable and
rapid, with a total time from sample-to-result as short
as 95 min. The addition of the extraction step alone
would add an additional 1 h approximately and the
performance of assays with the singleplex format
would significantly increase the time to result even
further (preparation of three reactions instead of one
Fig. 3 A three-step process from sample lysis to gene expression analysis for two populations (Resistant vs Susceptible, n = 3 replicates each). For
the abovementioned samples a total-time-to-results of approximately 95 min is needed
Table 4 Cost comparison of triplex TaqMan vs singleplex SYBR
Green approach. This is a rough cost estimation for measuring
the gene expression levels of eight detox genes and one
normaliser gene in 12 samples on a standard 96-well plate
format
Consumables and
reagents
TaqMan triplex
RT-qPCR
SYBR Green
singleplex RT-qPCR
96-well plastic
plate and optical film
1 × 6.50 € = 6.50 € 3 × 6.50 € = 19.50 €
Mastermix 1 × 25.00 € = 25.00 € 2.25 × 25.00 € = 56.25 €
Primers 1 × 0.50 € = 0.50 € 2.25 × 0.50 € = 1.13 €
TaqMan Probes 1 × 10.00 € = 10.00 € –
Total cost 42.00 € 76.88 €
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and possibly more than one qPCR run required
dependent on the number of samples). The
direct-in-lysates RT-qPCR approach seems to produce
more variable results (indicated by broader 95% CIs)
compared to the standard RNA extraction method
and thus more technical replicates might be required
to achieve similar precision.
Our method has important features for the future de-
velopment of diagnostic kits. It does not require a cold
chain, as it can be used with samples preserved in RNA-
later® and could be performed with ready-to-use lyophi-
lised RT-PCR enzyme/primer/probe pellets. It is also
flexible to include additional genetic traits for insecticide
resistance as they evolve and to expand to other species.
Furthermore, the format we suggest could include other
diagnostic markers such as species identification [39]
and Plasmodium detection [40] markers. Thus, the
multiplex assays described here along with the suggested
expansions represent ideal candidates for incorporation
in automated diagnostic platforms for mosquito vector
surveillance such as the DMC-MALVEC-LabDisk cur-
rently under development [22].
Conclusions
The novel multiplex qRT-PCR assays for monitoring the
expression levels of genes previously associated with
metabolic resistance in An. gambiae (s.l.) are simple to
perform, robust, rapid, cost-effective and work with
RNAlater® preserved field-collected mosquitoes that can
be shipped at room temperature. The approach we sug-
gest here is, therefore, relevant and suitable for insecti-
cide resistance management (IRM) programmes, on the
one hand because large numbers of specimens can be
handled without extra care, and on the other hand be-
cause the speed of the assay allows for producing data as
required within short time. The specificity of P450-based
metabolic resistance against some but not other active
ingredients, as well as the “unexpected case” of
cross-resistance against different groups of insecticides
[41], indicates that the development of diagnostic tools
able to detect specific detoxification enzyme-based re-
sistance is important. Together with bioassays and mo-
lecular tests for target site resistance detection, our
assays could identify resistance at an early stage and
guide efficient and sustainable IRM strategies.
Additional Files
Additional file 1: Table S1. List of laboratory strains and their
characteristics. Table S2. Primers and probes used in the study. Table
S3. Expression analysis in field-caught samples from Bioko (Industrial area)
vs Kisumu susceptible strain. Table S4. Expression analysis in field-caught
samples from Bioko (Hospital area) vs Kisumu susceptible strain. Table
S5. Accordance between expression levels measured in mosquito lysates
by direct qPCR and purified eluates after nucleic acid extraction (n = 8)
(DOCX 29 kb)
Additional file 2: Figure S1. Primer and probe design strategy using
Detox (A), consisting of RPS7 (normaliser), CYP6P3 (target gene 1), CYP6M2
(target gene 2) as an example. For each gene either the forward (RPS7
and CYP6P3) or the reverse primer (CYP6M2) spanned two exons in order
to avoid DNA amplification. Boxes indicate exons, lines indicate introns.
Abbreviations: F, forward primer; R, reverse primer; P, TaqMan probe
labelled with different dyes for each gene; bp, base pairs. Figure S2.
Results from the primer matrices experiments for each individual gene. Ct
values are plotted versus forward and reverse primer concentration
concentrations. “X” indicates the selected combination of forward and
reverse primer concentrations by using as criterion the lowest
concentration that gives the earliest Ct values. Figure S3. Agarose gel
(2.0% w/v) electrophoresis indicating the specificity of the study’s assays.
Additional specificity is achieved with probe hybridisation (TaqMan
chemistry) (DOCX 3803 kb)
Abbreviations
CI: Confidence interval; CV: Coefficient of variation;
DDT: Dichlordiphenyltrichlorethan; IR: Insecticide resistance; IRM: Insecticide
resistance management; RT-qPCR: Reverse transcription qPCR
Acknowledgements
The following reagent was obtained through BEI Resources: ZANU (MRA-
594), RSP (MRA-334), Akron (MRA-913). We specially thank Dr Paul Howell
from CDC for organising and sending the abovementioned samples. We
thank Fast Track Diagnostics (FTD) for supplying us with the RT-PCR master-
mix and Liverpool Insect Testing Establishment (LITE) for providing the VK7
and Tiassalé Anopheles gambiae strains.
Funding
This project was funded by the European Union Horizon 2020 Framework
Programme (688207-DMC-MALVEC).
Availability of data and materials
Data supporting the conclusions of this article are included within the article
and its additional files. The datasets used and/or analysed during the present
study are available from the corresponding author upon reasonable request.
Authors’ contributions
JV and KM conceptualised and designed the study. KM performed the
experiments and the statistical analysis. KM and JV drafted manuscript with
input from all authors. NW provided and prepared samples for the study.
NW and PM critically reviewed and amended the manuscript. SM and IE
performed the quality control of primer/probe multiplexing. All authors read
and approved the final manuscript.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Institute of Molecular Biology and Biotechnology, Foundation for Research
and Technology-Hellas, 70013 Heraklion, Greece. 2Department of
Epidemiology and Public Health, Swiss Tropical and Public Health Institute,
Socinstrasse 57, P.O. Box, CH-4002 Basel, Switzerland. 3University of Basel,
Petersplatz 1, P.O. Box, CH-4001 Basel, Switzerland. 4Fast Track Diagnostics, a
Siemens Healthineers Company, Esch-sur-Alzette 4354, Luxembourg.
Mavridis et al. Parasites & Vectors            (2019) 12:9 Page 11 of 13
5Pesticide Science Laboratory, Department of Crop Science, Agricultural
University of Athens, 11855 Athens, Greece.
Received: 24 August 2018 Accepted: 3 December 2018
References
1. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The
effect of malaria control on Plasmodium falciparum in Africa between 2000
and 2015. Nature. 2015;526:207–11.
2. Ranson H, N’Guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V. Pyrethroid
resistance in African anopheline mosquitoes: what are the implications for
malaria control? Trends Parasitol. 2011;27:91–8.
3. Edi CV, Koudou BG, Jones CM, Weetman D, Ranson H. Multiple-insecticide
resistance in Anopheles gambiae mosquitoes, southern Côte d’Ivoire. Emerg
Infect Dis. 2012;18:1508–11.
4. Liu N. Insecticide resistance in mosquitoes: impact, mechanisms, and
research directions. Annu Rev Entomol. 2015;60:537–59.
5. Muller P, Warr E, Stevenson BJ, Pignatelli PM, Morgan JC, Steven A, et al.
Field-caught permethrin-resistant Anopheles gambiae overexpress CYP6P3, a
P450 that metabolises pyrethroids. PLoS Genet. 2008;4:e1000286.
6. Stevenson BJ, Bibby J, Pignatelli P, Muangnoicharoen S, O’Neill PM, Lian LY,
et al. Cytochrome P450 6M2 from the malaria vector Anopheles gambiae
metabolizes pyrethroids: sequential metabolism of deltamethrin revealed.
Insect Biochem Mol Biol. 2011;41:492–502.
7. Chiu TL, Wen Z, Rupasinghe SG, Schuler MA. Comparative molecular
modeling of Anopheles gambiae CYP6Z1, a mosquito P450 capable of
metabolizing DDT. Proc Natl Acad Sci USA. 2008;105:8855–60.
8. Ibrahim SS, Riveron JM, Stott R, Irving H, Wondji CS. The cytochrome P450
CYP6P4 is responsible for the high pyrethroid resistance in knockdown
resistance-free Anopheles arabiensis. Insect Biochem Mol Biol. 2016;68:23–32.
9. Yunta C, Grisales N, Nasz S, Hemmings K, Pignatelli P, Voice M, et al.
Pyriproxyfen is metabolized by P450s associated with pyrethroid resistance
in An. gambiae. Insect Biochem Mol Biol. 2016;78:50–7.
10. Vontas J, Grigoraki L, Morgan J, Tsakireli D, Fuseini G, Segura L, et al. Rapid
selection of a pyrethroid metabolic enzyme CYP9K1 by operational malaria
control activities. Proc Natl Acad Sci USA. 2018;115:4619–24.
11. Ranson H, Jensen B, Wang X, Prapanthadara L, Hemingway J, Collins FH.
Genetic mapping of two loci affecting DDT resistance in the malaria vector
Anopheles gambiae. Insect Mol Biol. 2000;9:499–507.
12. Riveron JM, Yunta C, Ibrahim SS, Djouaka R, Irving H, Menze BD, et al. A
single mutation in the GSTe2 gene allows tracking of metabolically based
insecticide resistance in a major malaria vector. Genome Biol. 2014;15:R27.
13. Bass C, Nikou D, Vontas J, Donnelly MJ, Williamson MS, Field LM. The Vector
Population Monitoring Tool (VPMT): high-throughput DNA-based
diagnostics for the monitoring of mosquito vector populations. Malar Res
Treat. 2010;2010:190434.
14. Donnelly MJ, Isaacs AT, Weetman D. Identification, validation, and
application of molecular diagnostics for insecticide resistance in malaria
vectors. Trends Parasitol. 2016;32:197–206.
15. Brogdon WG, McAllister JC. Insecticide resistance and vector control. Emerg
Infect Dis. 1998;4:605–13.
16. Brogdon WG. Biochemical resistance detection: an alternative to bioassay.
Parasitol Today. 1989;5:56–60.
17. WHO. Test procedures for insecticide resistance monitoring in malaria
vector mosquitoes. 2nd edition. Geneva: World Health Organization; 2016.
18. Vulule JM, Beach RF, Atieli FK, McAllister JC, Brogdon WG, Roberts JM, et al.
Elevated oxidase and esterase levels associated with permethrin tolerance
in Anopheles gambiae from Kenyan villages using permethrin-impregnated
nets. Med Vet Entomol. 1999;13:239–44.
19. Brooke BD, Kloke G, Hunt RH, Koekemoer LL, Temu EA, Taylor ME, et al.
Bioassay and biochemical analyses of insecticide resistance in southern
African Anopheles funestus (Diptera: Culicidae). Bull Entomol Res. 2001;91:
265–72.
20. Morou E, Dowd AJ, Rajatileka S, Steven A, Hemingway J, Ranson H, et al. A
simple colorimetric assay for specific detection of glutathione-S transferase
activity associated with DDT resistance in mosquitoes. PLoS Negl Trop Dis.
2010;4:e808.
21. Riga M, Tsakireli D, Ilias A, Morou E, Myridakis A, Stephanou EG, et al.
Abamectin is metabolized by CYP392A16, a cytochrome P450 associated
with high levels of acaricide resistance in Tetranychus urticae. Insect
Biochem Mol Biol. 2014;46:43–53.
22. Vontas J, Mitsakakis K, Zengerle R, Yewhalaw D, Sikaala CH, Etang J, et al.
Automated innovative diagnostic, data management and communication
tool, for improving malaria vector control in endemic settings. Stud Health
Technol Inform. 2016;224:54–60.
23. Djouaka RF, Bakare AA, Coulibaly ON, Akogbeto MC, Ranson H, Hemingway J,
et al. Expression of the cytochrome P450s, CYP6P3 and CYP6M2 are
significantly elevated in multiple pyrethroid resistant populations of Anopheles
gambiae s.s. from southern Benin and Nigeria. BMC Genomics. 2008;9:538.
24. Lines JD, Nassor NS. DDT resistance in Anopheles gambiae declines with
mosquito age. Med Vet Entomol. 1991;5:261–5.
25. Vulule JM, Beach RF, Atieli FK, Mount DL, Roberts JM, Mwangi RW. Long-
term use of permethrin-impregnated nets does not increase Anopheles
gambiae permethrin tolerance. Med Vet Entomol. 1996;10:71–9.
26. Prapanthadara LA, Hemingway J, Ketterman AJ. DDT-resistance in Anopheles
gambiae (Diptera: Culicidae) from Zanzibar, Tanzania, based on increased
DDT-dehydrochlorinase activity of glutathione S-transferases. Bull Entomol
Res. 1995;85:267–74.
27. Edi CV, Djogbenou L, Jenkins AM, Regna K, Muskavitch MA, Poupardin R, et
al. CYP6 P450 enzymes and ACE-1 duplication produce extreme and
multiple insecticide resistance in the malaria mosquito Anopheles gambiae.
PLoS Genet. 2014;10:e1004236.
28. Diabate A, Baldet T, Chandre F, Akoobeto M, Guiguemde TR, Darriet F, et al.
The role of agricultural use of insecticides in resistance to pyrethroids in
Anopheles gambiae s.l. in Burkina Faso. Am J Trop Med Hyg. 2002;67:617–22.
29. Reid JA. Pupal differences between species A and B of the Anopheles
gambiae group from Kisumu, East Africa. Mosq Syst. 1975;7:299–302.
30. Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, et al.
Geneious Basic: an integrated and extendable desktop software platform for
the organization and analysis of sequence data. Bioinformatics. 2012;28:1647–9.
31. Gardner SN, Slezak T. Simulate_PCR for amplicon prediction and annotation from
multiplex, degenerate primers and probes. BMC Bioinformatics. 2014;15:237.
32. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment
search tool. J Mol Biol. 1990;215:403–10.
33. Giraldo-Calderon GI, Emrich SJ, MacCallum RM, Maslen G, Dialynas E, Topalis
P, et al. VectorBase: an updated bioinformatics resource for invertebrate
vectors and other organisms related with human diseases. Nucleic Acids
Res. 2015;43:D707–13.
34. Vallone PM, Butler JM. AutoDimer: a screening tool for primer-dimer and
hairpin structures. Biotechniques. 2004;37:226–31.
35. Mutunga JM, Anderson TD, Craft DT, Gross AD, Swale DR, Tong F, et al.
Carbamate and pyrethroid resistance in the akron strain of Anopheles
gambiae. Pestic Biochem Physiol. 2015;121:116–21.
36. Giavarina D. Understanding Bland Altman analysis. Biochem Med (Zagreb).
2015;25:141–51.
37. Pfaffl MW, Horgan GW, Dempfle L. Relative Expression Software Tool (REST)
for group-wise comparison and statistical analysis of relative expression
results in real-time PCR. Nucleic Acids Res. 2002;30:e36.
38. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The
MIQE guidelines: minimum information for publication of quantitative real-
time PCR experiments. Clin Chem. 2009;55:611–22.
39. Bass C, Williamson MS, Wilding CS, Donnelly MJ, Field LM. Identification of
the main malaria vectors in the Anopheles gambiae species complex using a
TaqMan real-time PCR assay. Malar J. 2007;6:155.
40. Kefi M, Mavridis K, Simoes ML, Dimopoulos G, Siden-Kiamos I, Vontas J. New
rapid one-step PCR diagnostic assay for Plasmodium falciparum infective
mosquitoes. Sci Rep. 2018;8:1462.
41. Nauen R, Vontas J, Kaussmann M, Wolfel K. Pymetrozine is hydroxylated by
CYP6CM1, a cytochrome P450 conferring neonicotinoid resistance in
Bemisia tabaci. Pest Manag Sci. 2013;69:457–61.
42. Vector Base data, Kwiatkowska et al, Multi-insecticide resistant VK
population. 2013. https://www.vectorbase.org/expression-browser/
experiment/E-MTAB-1083. Accessed 21 July 2018.
43. Nikou D, Ranson H, Hemingway J. An adult-specific CYP6 P450 gene is
overexpressed in a pyrethroid-resistant strain of the malaria vector,
Anopheles gambiae. Gene. 2003;318:91–102.
44. David JP, Strode C, Vontas J, Nikou D, Vaughan A, Pignatelli PM, et al. The
Anopheles gambiae detoxification chip: a highly specific microarray to study
metabolic-based insecticide resistance in malaria vectors. Proc Natl Acad Sci
USA. 2005;102:4080–4.
Mavridis et al. Parasites & Vectors            (2019) 12:9 Page 12 of 13
45. Ding Y, Ortelli F, Rossiter LC, Hemingway J, Ranson H. The Anopheles
gambiae glutathione transferase supergene family: annotation, phylogeny
and expression profiles. BMC Genomics. 2003;4:35.
46. Toe KH, N'Fale S, Dabire RK, Ranson H, Jones CM. The recent escalation
in strength of pyrethroid resistance in Anopheles coluzzi in West Africa
is linked to increased expression of multiple gene families. BMC
Genomics. 2015;16:146.
Mavridis et al. Parasites & Vectors            (2019) 12:9 Page 13 of 13
